Investigating the health effects of sausages containing postbiotics

Investigating the microbial, physicochemical, organoleptic characteristics, shelf life and health effects of sausages containing postbiotic substitutes for nitrite during storage

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241023063473N1

Enrollment

Registered

2024-11-03

Start date

2024-10-29

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Hypercholestrplimia. Condition 2: Liver disaese. Hyperlipidemia, unspecified Toxic liver disease

Interventions

Intervention 1: Intervention group: Consuming sausage containing postbiotics for one month and three meals a week, one per meal. Intervention 2: Control group: Consuming sausage containing nitrite for

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: BMI below 30

Exclusion criteria

Exclusion criteria: History of high blood TG and cholesterol Cardiovascular diseases Diabetes Liver diseases Kidney diseases Underlying and chronic diseases People with allergies to sausage components

Design outcomes

Primary

Measure	Time frame
AST level. Timepoint: Before intervention, one month after intervention. Method of measurement: Use a lab kit.	—

Secondary

Measure	Time frame
FBS. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;Total cholestrol. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;HDL (High Density Lipoprotein) Cholesterol. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;LDL (Low Density Lipoprotein) Cholesterol. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;Triglyceride. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;HbA1C. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;SGPT. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab lit.;Alkaline Phosphatase (ALP). Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.	—

Measure

Time frame

FBS. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;Total cholestrol. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;HDL (High Density Lipoprotein) Cholesterol. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;LDL (Low Density Lipoprotein) Cholesterol. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;Triglyceride. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;HbA1C. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.;SGPT. Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab lit.;Alkaline Phosphatase (ALP). Timepoint: Before intervention, 1 month after intervention. Method of measurement: Use a lab kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrana Rahmannia

Karaj University of Medical Sciences

mrahmannia1379@gmail.com+98 26 3464 3705

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026